Status:
UNKNOWN
Personalized Targeted Therapy in Refractory or Relapsed Cancer in Childhood
Lead Sponsor:
St. Justine's Hospital
Conditions:
Pediatric Cancer
Eligibility:
All Genders
1-21 years
Brief Summary
A new research paradigm that involves sequencing tumor DNA/RNA to identify driver mutations, select among the Health Canada approved drugs (for adult cancers) known to block certain oncogenic pathways...
Eligibility Criteria
Inclusion
- At the time of enrollment:
- 21 year-old or less
- Poor prognosis biopsy-proven cancer of any type :
- Cancer (at initial diagnosis) known to be refractory to treatment
- Or cancer refractory to treatment
- Or relapsed cancer
- Written informed consent by patient, parents, or the legal guardians
Exclusion
- Estimated life expectancy of less than 3 months.
Key Trial Info
Start Date :
June 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2017
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02242552
Start Date
June 1 2014
End Date
June 1 2017
Last Update
September 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Sainte-Justine
Montreal, Quebec, Canada, H3T1C5